{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T20:22:23Z","timestamp":1750018943342},"reference-count":18,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.5693","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T18:12:13Z","timestamp":1459447933000},"page":"799-803","source":"Crossref","is-referenced-by-count":8,"title":["Thymic Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue with 8q24 Abnormality"],"prefix":"10.2169","volume":"55","author":[{"given":"Akihito","family":"Momoi","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriatsu","family":"Isahai","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Niigata Prefectural Central Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Ohshima","sequence":"additional","affiliation":[{"name":"Department of Pathology, School of Medicine, Kurume University, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadao","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Niigata University of Pharmacy and Applied Life Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Isaacson PG, Chott A, Nakamura S, M&uuml;ller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Swerdlow SH, Campo E, Harris NL, et al, Eds. IARC, Lyon, 2008: 214-217."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Isaacson PG, Chan JK, Tang C, Addis BJ. Low-grade B-cell lymphoma of mucosa-associated lymphoid tissue arising in the thymus. A thymic lymphoma mimicking myoepithelial sialadenitis. Am J Surg Pathol 14: 342-351, 1990.","DOI":"10.1097\/00000478-199004000-00005"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Inagaki H, Chan JK, Ng JW, et al. Primary thymic extranodal marginal-zone B-cell lymphoma of mucosa-associated lymphoid tissue type exhibits distinctive clinicopathological and molecular features. Am J Pathol 160: 1435-1443, 2002.","DOI":"10.1016\/S0002-9440(10)62569-2"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dierlamm J, Wlodarska I, Michaux L, et al. Genetic abnormalities in marginal zone B-cell lymphoma. Hematol Oncol 18: 1-13, 2000.","DOI":"10.1002\/(SICI)1099-1069(200003)18:1<1::AID-HON647>3.0.CO;2-G"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kominato S, Nakayama T, Sato F, et al. Characterization of chromosomal aberrations in thymic MALT lymphoma. Pathol Int 62: 93-98, 2012.","DOI":"10.1111\/j.1440-1827.2011.02764.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Takino H, Li C, Yamada S, et al. Thymic extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a gene methylation study. Leuk Lymphoma 54: 1742-1746, 2013.","DOI":"10.3109\/10428194.2013.765563"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Go H, Cho HJ, Paik JH, et al. Thymic extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a clinicopathological and genetic analysis of six cases. Leuk Lymphoma 52: 2276-2283, 2011.","DOI":"10.3109\/10428194.2011.596968"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Naithani R, Ngan BY, Roifman C, Crump M, Baruchel S, Abla O. Thymic mucosa-associated lymphoid tissue lymphoma in an adolescent girl. J Pediatr Hematol Oncol 34: 552-555, 2012.","DOI":"10.1097\/MPH.0b013e3182459f0a"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shimizu K, Ishii G, Nagai K, et al. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in the thymus: report of four cases. Jpn J Clin Oncol 35: 412-416, 2005.","DOI":"10.1093\/jjco\/hyi105"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Ortonne N, Copie-Bergman C, Remy P, et al. Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement. Virchows Arch 446: 189-193, 2005.","DOI":"10.1007\/s00428-004-1168-0"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Harigae H, Ichinohasama R, Miura I, et al. Primary marginal zone lymphoma of the thymus accompanied by chromosomal anomaly 46,X,dup(X)(p11p22). Cancer Genet Cytogenet 133: 142-147, 2002.","DOI":"10.1016\/S0165-4608(01)00568-4"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Sunohara M, Hara K, Osamura K, et al. Mucosa associated lymphoid tissue (MALT) lymphoma of the thymus with trisomy 18. Intern Med 48: 2025-2032, 2009.","DOI":"10.2169\/internalmedicine.48.2424"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lorsbach RB, Pinkus GS, Shahsafaei A, Dorfman DM. Primary marginal zone lymphoma of the thymus. Am J Clin Pathol 113: 784-791, 2000.","DOI":"10.1309\/H7V2-G9L4-GR9G-8GK0"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Chinen Y, Sakamoto N, Nagoshi H, et al. 8q24 amplified segments involve novel fusion genes between NSMCE2 and long noncoding RNAs in acute myelogenous leukemia. J Hematol Oncol 7: 68, 2014.","DOI":"10.1186\/s13045-014-0068-2"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Shtivelman E, Henglein B, Groitl P, Lipp M, Bishop JM. Identification of a human transcription unit affected by the variant chromosomal translocations 2;8 and 8;22 of Burkitt lymphoma. Proc Natl Acad Sci U S A 86: 3257-3260, 1989.","DOI":"10.1073\/pnas.86.9.3257"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takahashi Y, Sawada G, Kurashige J, et al. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 110: 164-171, 2014.","DOI":"10.1038\/bjc.2013.698"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Guan Y, Kuo WL, Stilwell JL, et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res 13: 5745-5755, 2007.","DOI":"10.1158\/1078-0432.CCR-06-2882"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ding C, Yang Z, Lv Z, et al. Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients. Oncol Lett 9: 955-963, 2015.","DOI":"10.3892\/ol.2014.2730"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/7\/55_55.5693\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T00:40:01Z","timestamp":1567730401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/7\/55_55.5693\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.5693","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}